期刊文献+

缺血性脑卒中治疗药物研究进展 被引量:61

The Research Progress of Drugs for Ischemic Stroke Treatment
下载PDF
导出
摘要 本文以缺血性脑卒中为主要研究对象,论述了缺血性脑卒中的发病机制,综述了脑卒中治疗药物的临床使用现状和研究进展.笔者从溶栓药物、抗血小板聚集药物、降纤和抗凝药物以及神经保护药物等几个方面总结了近年来缺血性脑卒中治疗药物的研究概况和研究热点,分析了脑卒中治疗药物研究存在的问题,并展望了脑卒中药物治疗的发展方向. The pathogenesis of ischemic stroke was discussed, and the clinical status and research progress of drugs for stroke treatment were also summarized in this review. The author enumerated the recent progress and focus of researches of drugs for ischemic stroke treatment about many drugs which included thrombolytic drugs, anti-platelet aggregation drugs, fibrinolytic drugs, anticoagulant drugs and neuroprotective drugs and so on. research problems of drugs for ischemic stroke treatment was analyzed and also prospected the development of drug for ischemic stroke treatment.
出处 《中央民族大学学报(自然科学版)》 2012年第2期65-70,共6页 Journal of Minzu University of China(Natural Sciences Edition)
基金 国家自然基金面上项目资助(NO.30973959) 中央民族大学自主科研计划项目资助 中央民族大学211工程三期创新人才培养项目资助
关键词 缺血性脑卒中 治疗药物 溶栓药物 神经保护药物 ischemic stroke drug treatment thrombolytic drugs neuroprotective drugs
  • 相关文献

参考文献24

  • 1侯训尧.青年脑卒中[J].山东医药,2008,48(23):109-110. 被引量:12
  • 2HACKE W, KASTE M, BLUHMKI E, et al. For the ECASS investigators thrombolysis with aheplase 3 to 4. 5 hours after acute ischemic stroke [ J ]. N Engl J Med, 2008, 359 ( 15 ) : 1317 - 1329.
  • 3WAHLGREN N, AHMED N, DAVALOS A, et al. Symptomatic intracerebral hemorrhage, moritality and independence at 3 month for patient treated 3 -4.5h after stroke onset in the sits thrombolysis register (SITS-ISTR) [ J ]. Cerebrovasc Dis. , 2008, 25 ( suppl 2) :3.
  • 4DEL ZOPOO GJ. SAVER JL, JAUCH EC. et al. Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart & Association/American Stroke Association Stroke [ J ]. American Heart& Association Stroke Council. ,2009,40:2945 - 2948.
  • 5ANZUNI A, NIAZ A, DURASTANI L, et al. Thrombolysis young patients: the SITS-MOST data [ J]. Cerebrovasc, Dis., 2008, 25(supp12):3.
  • 6NAGEL S, SCHELLINGER PD, HARTMANN M, et al. Thempy of acute basilar artery occlusion : intraarterial thrombolysis alone versus bridging therapy[ J]. Cerebrevase Dis. ,2008,25 ( Suppl 2) : 12.
  • 7FENG WANG, DAN XU,HAO DUAN, et al. The clinical study of thrombolysis with rt-PA 50 mg intravenous in acute ischemic stroke within 6 hours of onset [ J]. Cerebroval Dis. , 2008,25:74.
  • 8OGAWA A, MORI E,MINEMATSU K, et al. Randomized trial of intra-arterial infusion of urokinase within 6 hours of middle cerebral artery stroke : the middle cerebral artery embolism local fibrinolytic iutervention trial (MELT) Japan Stroke[ J]. MELT Japan Study Group, 2007,38 : 2633 - 2639.
  • 9CHEN H, MO W, ZHANG Y, et al. Functional properties of a novel mutant of staphylokinase with platelet, targeted fibrinolysis and antiplatelet aggregatiion activities[ J]. Eur J Pharma~ol,2007,566: 137 - 144.
  • 10杨琴,承欧梅,彭国光,董为伟,谢鹏.降纤酶治疗脑梗死65例疗效观察[J].重庆医科大学学报,2008,33(z1):87-88. 被引量:2

二级参考文献97

共引文献96

同被引文献700

引证文献61

二级引证文献530

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部